These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23042805)

  • 1. Estrogen receptor-α, RBCK1, and protein kinase C β 1 cooperate to regulate estrogen receptor-α gene expression.
    Gustafsson Sheppard N; Heldring N; Dahlman-Wright K
    J Mol Endocrinol; 2012 Dec; 49(3):277-87. PubMed ID: 23042805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1.
    Gustafsson N; Zhao C; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2010 Feb; 70(3):1265-74. PubMed ID: 20103625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen.
    Donley C; McClelland K; McKeen HD; Nelson L; Yakkundi A; Jithesh PV; Burrows J; McClements L; Valentine A; Prise KM; McCarthy HO; Robson T
    Oncogene; 2014 Jun; 33(26):3441-50. PubMed ID: 23912458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
    Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
    J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells.
    Gong EY; Park E; Lee K
    Cancer Sci; 2010 Sep; 101(9):2019-25. PubMed ID: 20608937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
    Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
    Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
    Matthews J; Wihlén B; Thomsen J; Gustafsson JA
    Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ubiquitin ligase activity of RBCK1 and its inhibition by splice variant RBCK2 and protein kinase Cbeta.
    Tatematsu K; Yoshimoto N; Okajima T; Tanizawa K; Kuroda S
    J Biol Chem; 2008 Apr; 283(17):11575-85. PubMed ID: 18303026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
    Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
    Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
    BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters.
    Kininis M; Chen BS; Diehl AG; Isaacs GD; Zhang T; Siepel AC; Clark AG; Kraus WL
    Mol Cell Biol; 2007 Jul; 27(14):5090-104. PubMed ID: 17515612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
    Li Z; Su P; Ding Y; Gao H; Yang H; Li X; Yang X; Xia Y; Zhang C; Fu M; Wang D; Zhang Y; Zhuo S; Zhu J; Zhuang T
    Cell Commun Signal; 2022 Oct; 20(1):164. PubMed ID: 36280829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
    Band AM; Laiho M
    Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBCK1, a protein kinase CbetaI (PKCbetaI)-interacting protein, regulates PKCbeta-dependent function.
    Vallentin A; Mochly-Rosen D
    J Biol Chem; 2007 Jan; 282(3):1650-7. PubMed ID: 17121852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.
    Johnsen SA; Güngör C; Prenzel T; Riethdorf S; Riethdorf L; Taniguchi-Ishigaki N; Rau T; Tursun B; Furlow JD; Sauter G; Scheffner M; Pantel K; Gannon F; Bach I
    Cancer Res; 2009 Jan; 69(1):128-36. PubMed ID: 19117995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor.
    Dong J; Tsai-Morris CH; Dufau ML
    J Biol Chem; 2006 Jul; 281(27):18825-36. PubMed ID: 16651265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinetic model identifies phosphorylated estrogen receptor-α (ERα) as a critical regulator of ERα dynamics in breast cancer.
    Tian D; Solodin NM; Rajbhandari P; Bjorklund K; Alarid ET; Kreeger PK
    FASEB J; 2015 May; 29(5):2022-31. PubMed ID: 25648997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.
    Levy N; Zhao X; Tang H; Jaffe RB; Speed TP; Leitman DC
    Endocrinology; 2007 Jul; 148(7):3449-58. PubMed ID: 17395694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.